Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1765817
Max Phase: Preclinical
Molecular Formula: C19H18FNO3
Molecular Weight: 327.36
Molecule Type: Small molecule
Associated Items:
ID: ALA1765817
Max Phase: Preclinical
Molecular Formula: C19H18FNO3
Molecular Weight: 327.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)c1ccc(-c2cc3cc(OCCF)ccc3oc2=O)cc1
Standard InChI: InChI=1S/C19H18FNO3/c1-21(2)15-5-3-13(4-6-15)17-12-14-11-16(23-10-9-20)7-8-18(14)24-19(17)22/h3-8,11-12H,9-10H2,1-2H3
Standard InChI Key: YZOZLLOQVLMWIJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 327.36 | Molecular Weight (Monoisotopic): 327.1271 | AlogP: 3.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 42.68 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.95 | CX LogP: 3.60 | CX LogD: 3.60 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.67 | Np Likeness Score: -0.73 |
1. Wang C, Wu C, Zhu J, Miller RH, Wang Y.. (2011) Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination., 54 (7): [PMID:21391687] [10.1021/jm101489w] |
Source(1):